PPL and neoplasm: From a mechanistic standpoint, periplakin hypermethylation, which was observed to be higher in esophageal squamous cell carcinomas as compared to the normal tissue by bisulfite pyrosequencing, has emerged as an underlying epigenetic contributor to the reduced periplakin expression that compromises its tumor suppressor functions [56].